Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?

Gerald J Mizejewski Wadsworth Center, New York State Department of Health, Albany, NY, USA Abstract: Breast cancer and Alzheimer’s disease (AD) are major causes of death in older women. Interestingly, breast cancer occurs less frequently in AD patients than in the general...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Mizejewski GJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/2080831903f047d6a30e94ff839d1073
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2080831903f047d6a30e94ff839d1073
record_format dspace
spelling oai:doaj.org-article:2080831903f047d6a30e94ff839d10732021-12-02T00:16:49ZBreast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?1179-1314https://doaj.org/article/2080831903f047d6a30e94ff839d10732017-04-01T00:00:00Zhttps://www.dovepress.com/breast-cancer-and-amyloid-bodies-is-there-a-role-for-amyloidosis-in-ca-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Gerald J Mizejewski Wadsworth Center, New York State Department of Health, Albany, NY, USA Abstract: Breast cancer and Alzheimer’s disease (AD) are major causes of death in older women. Interestingly, breast cancer occurs less frequently in AD patients than in the general population. Amyloidosis, the aggregation of amyloid proteins to form amyloid bodies, plays a central role in the pathogenesis of AD and other human neuropathies by forming intracellular fibrillary proteins. Contrary to popular belief, amyloidosis is a common occurrence in mammalian cells, and has recently been reported to be a natural physiological process in response to environmental stress stimulations (such as pH and temperature extremes, hypoxia, and oxidative stress). Many proteins contain an intrinsic “amyloid-converting motif”, which acts in conjunction with a specific noncoding RNA to induce formation of proteinaceous amyloid bodies that are stored in intracellular bundles. In cancer cells such as breast and prostate, the process of amyloidosis induces cells to enter a dormant or resting stage devoid of cell division and proliferation. Therefore, cancer cells undergo growth cessation and enter a dormant stage following amyloidosis in the cell; this is akin to giving the cell AD to cease growth. Keywords: α-fetoprotein, noncoding RNA, amyloid bodies, dormancy, breast cancer, Alzheimer’s diseaseMizejewski GJDove Medical PressarticleAlpha-fetoproteinnon-coding RNAamyloid bodiesdormancybreast cancerAlzheimer’s diseaseNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 9, Pp 287-291 (2017)
institution DOAJ
collection DOAJ
language EN
topic Alpha-fetoprotein
non-coding RNA
amyloid bodies
dormancy
breast cancer
Alzheimer’s disease
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Alpha-fetoprotein
non-coding RNA
amyloid bodies
dormancy
breast cancer
Alzheimer’s disease
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Mizejewski GJ
Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
description Gerald J Mizejewski Wadsworth Center, New York State Department of Health, Albany, NY, USA Abstract: Breast cancer and Alzheimer’s disease (AD) are major causes of death in older women. Interestingly, breast cancer occurs less frequently in AD patients than in the general population. Amyloidosis, the aggregation of amyloid proteins to form amyloid bodies, plays a central role in the pathogenesis of AD and other human neuropathies by forming intracellular fibrillary proteins. Contrary to popular belief, amyloidosis is a common occurrence in mammalian cells, and has recently been reported to be a natural physiological process in response to environmental stress stimulations (such as pH and temperature extremes, hypoxia, and oxidative stress). Many proteins contain an intrinsic “amyloid-converting motif”, which acts in conjunction with a specific noncoding RNA to induce formation of proteinaceous amyloid bodies that are stored in intracellular bundles. In cancer cells such as breast and prostate, the process of amyloidosis induces cells to enter a dormant or resting stage devoid of cell division and proliferation. Therefore, cancer cells undergo growth cessation and enter a dormant stage following amyloidosis in the cell; this is akin to giving the cell AD to cease growth. Keywords: α-fetoprotein, noncoding RNA, amyloid bodies, dormancy, breast cancer, Alzheimer’s disease
format article
author Mizejewski GJ
author_facet Mizejewski GJ
author_sort Mizejewski GJ
title Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
title_short Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
title_full Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
title_fullStr Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
title_full_unstemmed Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
title_sort breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/2080831903f047d6a30e94ff839d1073
work_keys_str_mv AT mizejewskigj breastcancerandamyloidbodiesistherearoleforamyloidosisincancercelldormancy
_version_ 1718403788071501824